Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Down 12.2 %

ENZ stock opened at $0.33 on Monday. The firm’s fifty day moving average is $0.52 and its 200 day moving average is $0.82. Enzo Biochem has a 52 week low of $0.31 and a 52 week high of $1.30.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. The company had revenue of $7.33 million during the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Investors Weigh In On Enzo Biochem

Several institutional investors have recently added to or reduced their stakes in ENZ. Virtu Financial LLC purchased a new position in shares of Enzo Biochem in the fourth quarter valued at about $35,000. Lepercq Multi Asset Fund purchased a new stake in shares of Enzo Biochem during the fourth quarter worth about $88,000. Wittenberg Investment Management Inc. grew its stake in shares of Enzo Biochem by 60.1% in the fourth quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after purchasing an additional 70,400 shares during the last quarter. Geode Capital Management LLC increased its holdings in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares during the period. Finally, Mink Brook Asset Management LLC purchased a new position in Enzo Biochem during the 4th quarter valued at about $577,000. Hedge funds and other institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.